Hinge Health made a notable entrance onto the New York Stock Exchange, with its shares surging 23% above its initial public offering (IPO) price of $32, opening at $39.25. By the end of the day, the stock closed at $37.56, marking a 17% increase and pushing the company’s market capitalization beyond $3 billion. The IPO raised approximately $273 million, with Hinge Health itself selling 8.52 million of the 13.7 million total shares offered, while the remainder was sold by existing shareholders.
Digital Rehab Pioneer Spurs Hope for Revival in Stagnant Health-Tech IPO Market
Founded in 2014, Hinge Health offers digital solutions for treating musculoskeletal issues, chronic pain, and post-surgical rehabilitation. The company’s software enables patients to receive care remotely, aligning with trends in telehealth and digital medicine. Based in San Francisco, Hinge filed its initial prospectus in March 2025 and set its IPO price range at $28 to $32 earlier this month, eventually pricing at the high end of the range.
Hinge Health Surges in NYSE Debut as Investors Back Digital Rehab BreakthroughHinge’s IPO is being closely watched by Wall Street and the health-tech industry as a potential signal of renewed investor interest in digital health solutions. The tech IPO market has been stagnant since late 2021 due to economic headwinds, and digital health companies have especially struggled to go public. Hinge is seen as a pioneer in this space, with its IPO potentially paving the way for other companies, such as Omada Health, which recently filed for its own public debut.
Founders’ Personal Journeys Inspire Tech-Driven Rehab Solution, Attracting Strong Investor Support
CEO Daniel Perez highlighted that Hinge stands apart from other digital health companies by using technology to automate actual care delivery, which has attracted investor interest. The company was co-founded by Perez and Gabriel Mecklenburg, both of whom personally experienced lengthy recoveries requiring physical therapy. These experiences motivated the creation of a solution that could simplify and enhance the rehab process through digital tools.
Although Hinge’s IPO valuation of around $2.6 billion is a substantial drop from its $6.2 billion private valuation in 2021, it remains one of the best-capitalized companies in its category. The company has raised over $1 billion from prominent investors such as Insight Partners, Tiger Global, and Atomico. Ben Blume of Atomico praised Hinge for becoming a category leader and delivering meaningful improvements for those suffering from chronic pain. Hinge now trades under the ticker symbol “HNGE” on the NYSE, marking a significant milestone in its growth journey.
